CD4 and colorectal carcinoma: According to the absolute value of each lymphocyte subgroup (Table 2), the expression level of CD4+ TSCM in the CRC group was 4.01 (2.32–5.86), which significantly differed from that in the benign tumor group and healthy control group (Figure 2A).